Iterum Therapeutics PLC (ITRM) Insider Trading
- $13,114,367.00
- $26,603,154.04
- Dec. 22, 2023
- Michael W Dunne
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Dec. 22, 2023 | Director | 25,000 | $1.40 | Buy | $35,000.00 | |
| Nov. 22, 2023 | Director | 20,000 | $2.03 | Buy | $40,600.00 | |
| Nov. 20, 2023 | CEO | 10,000 | $1.59 | Buy | $15,900.00 | |
| Dec. 2, 2022 | Insider | 3,365 | $1.32 | Sell | $4,441.80 | |
| Sept. 19, 2022 | Director | 15,000 | $1.77 | Sell | $26,550.00 | |
| Sept. 16, 2022 | Director | 15,000 | $1.90 | Sell | $28,500.00 | |
| Sept. 14, 2022 | Director | 15,000 | $2.10 | Sell | $31,500.00 | |
| Sept. 12, 2022 | Director | 15,000 | $2.31 | Sell | $34,650.00 | |
| Sept. 9, 2022 | Director | 15,000 | $2.32 | Sell | $34,800.00 | |
| Sept. 7, 2022 | Director | 10,000 | $2.22 | Buy | $22,200.00 | |
| March 14, 2022 | CFO | 47,132 | $0.38 | Sell | $17,910.16 | |
| Feb. 11, 2021 | Major Shareholder | 10,000,000 | $2.59 | Sell | $25,900,000.00 | |
| Jan. 26, 2021 | CEO | 85,445 | $1.73 | Sell | $147,819.85 | |
| Jan. 26, 2021 | CFO | 33,868 | $1.73 | Sell | $58,591.64 | |
| Jan. 26, 2021 | Director | 33,143 | $1.73 | Sell | $57,337.39 | |
| Sept. 30, 2020 | CFO | 56,130 | $1.64 | Sell | $92,053.20 | |
| June 1, 2020 | Major Shareholder | 100,000 | $1.69 | Sell | $169,000.00 | |
| Nov. 30, 2018 | Director | 10,000 | $6.29 | Buy | $62,900.00 | |
| Oct. 30, 2018 | Director | 58,000 | $6.10 | Buy | $353,800.00 | |
| Sept. 4, 2018 | Insider | 500 | $10.00 | Buy | $5,000.00 | |
| Aug. 27, 2018 | Insider | 1,000 | $10.00 | Buy | $10,000.00 | |
| Aug. 23, 2018 | Director | 500 | $10.44 | Buy | $5,220.00 | |
| Aug. 17, 2018 | CEO | 2,000 | $8.73 | Buy | $17,460.00 | |
| May 30, 2018 | Director | 456,099 | $13.00 | Buy | $5,929,287.00 | |
| May 30, 2018 | Insider | 2,000 | $13.00 | Buy | $26,000.00 | |
| May 30, 2018 | CFO | 4,000 | $13.00 | Buy | $52,000.00 | |
| May 30, 2018 | CEO | 3,000 | $13.00 | Buy | $39,000.00 | |
| May 30, 2018 | Major Shareholder | 500,000 | $13.00 | Buy | $6,500,000.00 |
Insiders are both buying and selling Iterum Therapeutics PLC stock.
The insider traders at Iterum Therapeutics PLC are: Michael W Dunne, Brenton Karl Ahrens, Corey N Fishman, Judith M Matthews, Sofinnova Venture Partners Ix,, Paul R Edick, Sailaja Puttagunta, Mark Chin, David George Kelly, Judith M. Matthews, Alexander J Denner, and Patrick J Heron
The most active insider trader at Iterum Therapeutics PLC is Michael W Dunne with 7 trades.
Alexander J Denner has sold the most Iterum Therapeutics PLC stock with a total value of $51,800,000.00.
Sofinnova Venture Partners Ix, has bought the most Iterum Therapeutics PLC stock with a total value of $13,000,000.00.
The most recent insider trade for Iterum Therapeutics PLC was on Dec. 22, 2023.
The single biggest insider buy for Iterum Therapeutics PLC was from Sofinnova Venture Partners Ix, with a total value of $6,500,000.00 on May 30, 2018.
The single biggest insider sell for Iterum Therapeutics PLC was from Alexander J Denner with a total value of $25,900,000.00 on Feb. 11, 2021.